Clinical Research Directory
Browse clinical research sites, groups, and studies.
Deep Learning for Automated Discrimination Between Stage T1-T2 and T3 Renal Cell Carcinoma on Contrast-Enhanced CT
Sponsor: Peking University First Hospital
Summary
This study aims to develop and validate a contrast-enhanced CT-based deep-learning model for automatic and accurate preoperative discrimination between T1-T2 and T3 renal cell carcinoma. By quantifying the model's diagnostic performance on an independent test set-using AUC, sensitivity, specificity, positive/negative predictive values, and decision-curve analysis-we will establish a decision-support tool that can be seamlessly integrated into clinical PACS, thereby reducing staging errors, refining surgical planning, and improving patient outcomes.
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2024-09-01
Completion Date
2027-12-01
Last Updated
2025-09-10
Healthy Volunteers
Yes
Interventions
None intervention
this study is retrospective based on the CT images, which dose include any intervention.
Locations (1)
Peking University First Hospital, Beijing,
Beijing, China